Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists

Drug-induced pulmonary arterial hypertension (D-PAH) is a form of World Health Organization Group 1 pulmonary hypertension (PH) defined by severe small vessel loss and obstructive vasculopathy, which leads to progressive right heart failure and death. To date, 16 different compounds have been associ...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Physiol Lung Cell Mol Physiol
Egile Nagusiak: Orcholski, Mark E., Yuan, Ke, Rajasingh, Charlotte, Tsai, Halley, Shamskhou, Elya A., Dhillon, Navneet K., Voelkel, Norbert F., Zamanian, Roham T., de Jesus Perez, Vinicio A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Physiological Society 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032070/
https://ncbi.nlm.nih.gov/pubmed/29417823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00553.2017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak